US FDA Finds Carcinogen in Some Diabetes Drugs by Merck
The US Food and Drug Administration (FDA), said certain samples of sitagliptin, a compound in diabetes drugs Janumet and Januvia by Merck, were contaminated with a possible carcinogen. The US FDA said it will temporarily allow Merck to market and distribute drugs with sitagliptin, which contains a higher-than-normal acceptable amount of the impurity known as […]
Continue Reading